DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sep 2019 11:04 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...